The Patented Medicine Prices Review Board (PMPRB) has just released its second set of Draft Guidelines under the recently amended Patented Medicines Regulations (“Regulations”). This launches a 30-day consultation period for stakeholders to provide written comments on the new Draft Guidelines.
Stay tuned to PDCI’s TargetPharma for a summary of changes to the draft guidelines and implications for manufacturers, and join us for our free webinar for pharmaceutical industry members on Tuesday June 23.
PDCI is hosting a free webinar for pharmaceutical industry members on the new Draft Guidelines on June 23rd from 10:30am to noon.
Please contact Kimberly Robinson, PDCI’s Director of Pricing and Market Access if you have questions